{
  "actions": [
    {
      "acted_at": "2005-06-30T16:00:00-04:00", 
      "references": [
        {
          "reference": "CR H5522-5526, H5538-5539", 
          "type": "consideration"
        }, 
        {
          "reference": "CR H5522", 
          "type": "text"
        }
      ], 
      "text": "Amendment (A041) offered by Mr. Brown (OH).", 
      "type": "action"
    }, 
    {
      "acted_at": "2005-06-30T18:28:00-04:00", 
      "how": "roll", 
      "references": [], 
      "result": "fail", 
      "roll": 355, 
      "text": "On agreeing to the Brown (OH) amendment (A041) Failed by recorded vote: 141 - 284 (Roll no. 355).", 
      "type": "vote", 
      "vote_type": "vote", 
      "where": "h"
    }
  ], 
  "amendment_id": "hamdt434-109", 
  "amendment_type": "hamdt", 
  "amends_amendment": null, 
  "amends_bill": {
    "bill_id": "hr3058-109", 
    "bill_type": "hr", 
    "congress": 109, 
    "number": 3058
  }, 
  "amends_treaty": null, 
  "chamber": "h", 
  "congress": "109", 
  "description": null, 
  "house_number": 41, 
  "introduced_at": "2005-06-30", 
  "number": 434, 
  "purpose": "An amendment to prohibit the use of funds from being used by the Council of Economic Advisers to produce an Economic Report of the President regarding the average cost of developing and introducing a new prescription drug to the market at $800 million or more.", 
  "sponsor": {
    "district": "13", 
    "name": "Brown, Sherrod", 
    "state": "OH", 
    "thomas_id": "00136", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "fail", 
  "status_at": "2005-06-30T18:28:00-04:00", 
  "updated_at": "2013-07-17T08:16:18-04:00"
}